Advances in Radiation Therapy for Brain Metastases
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 April 2026 | Viewed by 19
Special Issue Editor
Special Issue Information
Dear Colleagues,
Brain metastases develop in 20% to 40% of patients with cancer and can have a significant effect on patient survivorship because of the detrimental effects on neurocognitive function, neurologic symptoms, and survival. This Special Issue, “Advances in Radiation Therapy for Brain Metastases”, will focus on recent developments in the management of patients with brain metastases, including advanced radiation therapy (RT) techniques such as stereotactic radiosurgery (SRS) and hippocampal avoidance whole brain radiation therapy (HA-WBRT) to reduce side effects of RT, and more sophisticated tools, like radiomics and/or artificial intelligence, to detect brain metastasis, to predict tumor control, to contribute efficiently to treatment planning, to differentiate tumor progression from radiation necrosis, and to estimate patient survival. Furthermore, advanced imaging with PET tracers and multiparametric magnetic resonance imaging could refine several steps of the RT process. Besides progress in RT, emerging systemic therapies such as targeted therapies and immunotherapy claim their role as alternatives or adjuncts to RT and should be integrated in the contemporary management of brain metastases. This Special Issue will address these topics by an international team of experts in the field.
Dr. Luis A. Pérez-Romasanta
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain metastasis
- metastatic brain tumor
- imaging
- radiotherapy
- stereotactic radiosurgery
- radiomics
- machine learning
- magnetic resonance imaging
- positron emission tomography
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
